
A two-step workflow based on plasma p-tau217 to screen for amyloid β positivity with further confirmatory testing only in uncertain cases
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBzVlFkR09qanpRV2JEMVdSXzBKODVqbHREZXhNLXhFY0p4d3VfYzhNTFFGejN5Ql9fVXl6R3JBSjBrdHNIV3NBRGREZU55WXowSU4tOWtzTzRKM0JEYVhN?oc=5" target="_blank">A two-step workflow based on plasma p-tau217 to screen for amyloid β positivity with further confirmatory testing only in uncertain cases</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>

